As many of you are aware, I was asked to go to India with a team of international headache experts to educate local providers. Each one of us on the team had a specific purpose and for me, it was to focus on the treatment of migraine in women. The need for good migraine management in India is great. With a population of over 1.3 billion, the estimated prevalence of migraine in India is over 150,000 million. By comparison, the prevalence of migraine in the United States is 38 million.
A newly formed non-profit healthcare organization in India has asked a small team of US physicians to lead the way in educating Primary Care Physicians and neurologists about migraine. Dr. Hutchinson's focus will be the importance of treating migraine in women including the right for women to access medical care in the face of local [...]
Dr. Susan Hutchinson joined Dr. Jack Schim for a live Webcast on Thursday evening, October 25th, to discuss Ajovy, the second CGRP monoclonal Antibody approved for migraine prevention. It is an injection and offers the option of quarterly or monthly dosing.
Dr. Hutchinson 2nd Author On An Abstract Titled “Patterns and Characterization of Acute Prescription Headache Medication Use: Results from the CaMEO study”
Dr. Hutchinson was 2nd author on an abstract titled "Patterns and Characterization of Acute Prescription Headache Medication Use: Results from the CaMEO study" that was accepted as a poster presentation both at the recent American Headache Society Scientific Symposium in June 2018 and at the Diamond Headache Clinic Research & Educational Foundation in July 2018.
Reader’s Digest Online has included MigraineX and Dr. Hutchinson in an article titled, “The Sneaky Warning Signs a Migraine Is Coming—and How to Stop Them.”
Dr Susan Hutchinson recounts her journey as a doctor who suffers from migraine and how she has learned to manage the condition to improve her quality of life.
Professor Gretchen Tietjen recently received the annual John Graham lecture award from Paul Rizzoli and thanked friends and collaborators including Lynne Osborn Geweke, Dawn Buse, Sheena K. Aurora and Susan Lynn Hutchinson. "I am so happy for Dr. Gretchen Tietjen to receive this prestigious award. I was happy to be part of our Women's Issues [...]
A new category of medication for prevention of migraine is in the late stages of clinical trials and is expected to be available by early 2018. This category is called CGRP Monoclonal Antibodies.
The Migraine World Summit returns this April 23 – 29, 2017 to bring together over 30 top experts and doctors to provide answers, new treatments, research and best practices for migraine and chronic headache. It's available to anyone with an internet connection. Dr. Susan Hutchinson is one of the featured specialists. The Migraine World Summit returns this April 23 – 29, 2017 to bring together over 30 top experts and doctors to provide answers, new treatments, research and best practices for migraine and chronic headache. It's available to anyone with an internet connection. Dr. Susan Hutchinson is one of the featured specialists. Register for FREE now by clicking here.
When a severe migraine hits, many sufferers end up in the Emergency Room (ER). This is not ideal for many reasons including the long wait to be seen, the noise and bright lights in the ER, the attitude of the ER staff often treating the migraine patient as a narcotic seeker, and lastly, the cost. There are several alternatives to the ER including an urgent care center, home rescue, or an infusion center